Add a listing
    Add a listing

    HCW Biologics

      Drugs that modulate immune system, inflaming, and cellular senescence

    General
    • Headquarters

      Miramar, Florida, United States

    • Founders & Team

      Hing C. Wong, PhD

    • Year Founded

      2018

    • Number of employees

      200

    • Company type

      Private company

    • Funding stage

      Series C

    • Total funding ($M)

      39.3

    • Investors

      Pacific Treasure Global, Axone Capital, Deepwork Capital, Golden Triangle Ventures, MedMira

    Technical Details
    • Aging Target

      Cellular senescence, Immunosenescence

    • Product modality

      proteins

    About

    HCW Biologics is an innovative immunotherapy company developing novel therapeutics designed to disrupt the link between chronic, low-grade inflammation and age-related disorders. This field, known as inflammaging, targets the unresolved inflammatory responses and chronic, low-grade inflammation associated with advancing age and believed to be a significant contributing factor to cancer and several chronic conditions, including cardiovascular disease, diabetes, neurodegenerative disease, and autoimmune disease.

    Categories

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In